Aesthetic Devices refers to devices used in cosmetic treatments such as Implants, Injectables, Laser Resurfacing and Body Contouring that are used to beautify, correct, and improve body contour. Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. GlobalData uses proprietary data and analytics to provide a comprehensive report on the aesthetic injectables devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the aesthetic injectables market in China was Galderma followed by Allergan Aesthetics, Merz Pharma GmbH & Co and Sinclair Pharma.
Aesthetic Injectables helps in achieving a more youthful appearance by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic Injectables are classified based on their molecular composition. Aesthetic Injectables include Botulinum Toxin Type A, Hyaluronic Acid Fillers, and Non-Hyaluronic Acid Fillers.
The value of the aesthetic injectables devices market within China was expected to be over $1500m in 2023.
For the latest complete market share analysis of aesthetic injectables device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
